Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A model of consumers' perceptions of food additives and consequent purchasing behaviour / Emmerentia Gertruida Dicks

Autor: Dicks, Emmerentia Gertruida

The primary objective of this study was to apply the Elaboration Likelihood Model of persuasive communication to consumers' perceptions of food additive labelling. The model was used to explain how consumer information processing influences consumers

Externí odkaz: http://hdl.handle.net/10394/1608

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer.

Autor: Song H; Department of Oncology, University of Cambridge, Cambridge, Cambridgeshire, UK., Dicks EM; Department of Oncology, University of Cambridge, Cambridge, Cambridgeshire, UK., Tyrer J; Department of Oncology, University of Cambridge, Cambridge, Cambridgeshire, UK., Intermaggio M; School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Chenevix-Trench G; Cancer Genetics, Queensland Institute of Medical Research-QIMR, Herston, Queensland, Australia., Bowtell DD; Cancer Genomics and Genetics and Women's Cancer Programs, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Traficante N; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Group A; QIMR Berghofer Department of Genetics and Computational Biology, Herston, Queensland, Australia.; Department of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Brenton J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, Cambridgeshire, UK., Goranova T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, Cambridgeshire, UK., Hosking K; Department of Oncology, University of Cambridge, Cambridge, Cambridgeshire, UK., Piskorz A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, Cambridgeshire, UK., van Oudenhove E; Laura and Isaac Perlmutter Cancer Center, New York University, New York, New York, USA., Doherty J; Huntsman Institute, University of Utah, Salt Lake City, Utah, USA., Harris HR; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Rossing MA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Duerst M; Department of Gynaecology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Thüringen, Germany., Dork T; Gynaecology Research Unit, Hannover Medical School, Hannover, Niedersachsen, Germany., Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, Hannover, Niedersachsen, Germany.; Department of Gynaecology, NN Alexandrov National Cancer Centre, Minsk, Minsk, Belarus., Modugno F; Womens Cancer Research Center, Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Moysich K; Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA., Odunsi K; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA., Ness R; School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas, USA., Karlan BY; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Lester J; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Kobenhavn, Denmark., Krüger Kjaer S; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Kobenhavn, Denmark., Høgdall E; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Kobenhavn, Denmark.; Department of Pathology, Herlev Hospital, University of Copenhagen, Kobenhavn, Denmark., Campbell IG; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Research, Cancer Genomics and Genetics, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology, Barcelona, Catalunya, Spain., Pujara MA; Translational Research Laboratory, Catalan Institute of Oncology, Barcelona, Catalunya, Spain., Cunningham J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Vierkant R; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA., Winham SJ; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA., Hildebrandt M; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Huff C; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li D; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wu X; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yu Y; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Permuth JB; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA., Levine DA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, New York University, New York, New York, USA., Schildkraut JM; Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA., Riggan MJ; Department of Gynecologic Oncology, Duke University Hospital, Durham, North Carolina, USA., Berchuck A; Department of Gynecologic Oncology, Duke University Hospital, Durham, North Carolina, USA., Webb PM; Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Group OS; Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Cybulski C; Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Zachodniopomorskie, Poland., Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Zachodniopomorskie, Poland., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Zachodniopomorskie, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University in Szczecin, Szczecin, Zachodniopomorskie, Poland., Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Zachodniopomorskie, Poland., Alsop J; Department of Oncology, University of Cambridge, Cambridge, Cambridgeshire, UK., Harrington P; Department of Oncology, University of Cambridge, Cambridge, Cambridgeshire, UK., Chan I; School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Menon U; MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, London, UK., Pearce CL; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA., Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., de Fazio A; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia., Kennedy CJ; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia., Goode E; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, USA., Ramus S; School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.; Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia., Gayther S; Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, California, USA., Pharoah P; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK pp10001@medschl.cam.ac.uk.

Publikováno v: Journal of medical genetics [J Med Genet] 2021 May; Vol. 58 (5), pp. 305-313. Date of Electronic Publication: 2020 Jun 16.